Literature DB >> 15454208

SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa.

Joanne M Smallheer1, Richard S Alexander, Jianmin Wang, Shuaige Wang, Suanne Nakajima, Karen A Rossi, Angela Smallwood, Frank Barbera, Debra Burdick, Joseph M Luettgen, Robert M Knabb, Ruth R Wexler, Prabhakar K Jadhav.   

Abstract

Modifications to the P4 moiety and pyrazole C3 substituent of factor Xa inhibitor SN-429 provided several new compounds, which are 5-10nM inhibitors of factor IXa. An X-ray crystal structure of one example complexed to factor IXa shows that these compounds adopt a similar binding mode to that previously observed with pyrazole inhibitors in the factor Xa active site both with regard to how the inhibitor binds and the position of Tyr99.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454208     DOI: 10.1016/j.bmcl.2004.08.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

2.  Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.

Authors:  Aiming Sun; Jeong-Joong Yoon; Yan Yin; Andrew Prussia; Yutao Yang; Jaeki Min; Richard K Plemper; James P Snyder
Journal:  J Med Chem       Date:  2008-06-05       Impact factor: 7.446

3.  In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.

Authors:  Andrea Savarino
Journal:  Retrovirology       Date:  2007-03-20       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.